In a previous study, Cooks et al. demonstrated the extensive accumulation of mutant p53 protein in inflammatory colon cancer glands and that this was associated with NF-κB activation and sustained DNA damage [19]; these findings further verified the fact that mutant p53 can promote the activation of NF-κB. Here, NFKB1 is linked to colonic neoplasm.